FAQ

Frequently Asked Questions (FAQ)

We’ve put together some commonly asked questions to give you more information about TYME. If you have questions that you can’t find the answer to, please use our contact form. We also encourage you to speak with your doctor.

What is SM-88?

SM-88 is an oral investigational modified proprietary tyrosine derivative that is believed to interrupt the metabolic processes of cancer cells by breaking down the cells’ key defenses and leading to cell death through oxidative stress and exposure to the body’s natural immune system. Clinical trial data have shown that SM-88 has demonstrated encouraging tumor responses across 15 different cancers, including pancreatic, lung, breast, prostate and sarcoma cancers with minimal serious grade 3 or higher adverse events. SM-88 is an investigational therapy that is not approved for any indication in any disease.

back to top

Do you have a trial for pancreatic cancer?

At this time, we do not have any ongoing trials evaluating our lead cancer metabolism-based therapy (CMBT), SM-88, as a potential treatment for patients with pancreatic cancer. For more information, please visit us at TYMEtrials.com.

back to top

Do you have a trial for sarcoma?

Yes, we do have an ongoing trial evaluating our lead cancer metabolism-based therapy (CMBT), SM-88, as a potential treatment for patients with Ewing’s and high-risk sarcoma. For more information, please visit us at TYMEtrials.com.

back to top

Do you have a trial for prostate cancer?

Our clinical trial evaluating SM-88 as a potential treatment for patients with recurring prostate cancer is now completed. The purpose of this study was to evaluate the safety, pharmacokinetics, and efficacy of SM-88 in patients with prostate cancer that has not become metastatic.

The final data were presented at the European Society of Medical Oncology Congress (ESMO) held on September 27- October 1, 2019 in Barcelona, Spain. For more information, please visit us at TYMEtrials.com.

back to top

Will you be opening trials for other cancers?

At this time, we do not have information to provide for the opening of trials for other cancers. Please visit TYMEtrials.com for any updates for the potential opening of new cancer trials.

back to top

Do you know any medical center that has a trial using SM-88 for pancreatic or sarcoma cancers?

Please visit TYMEtrials.com for more information.

back to top

Can I pay for SM-88?

SM-88 is an investigational therapy that is not approved for any indication and is not available for purchase.

back to top

Can you send me literature on SM-88?

Overview of SM-88 can be found at tymeinc.com/pipeline/sm-88-overview/

back to top